Evaluation of the pulmonary and systemic immunogenicity of Fluidosomes, a fluid liposomal–tobramycin formulation for the treatment of chronic infections in lungs-Reference-Cited by-同舟云学术

Evaluation of the pulmonary and systemic immunogenicity of Fluidosomes, a fluid liposomal–tobramycin formulation for the treatment of chronic infections in lungs

Published:1999-08 Issue:2-3 Volume:1428 Page:334-340
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Sachetelli Sébastien,Beaulac Christian,Riffon Renée,Lagacé Jacqueline

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference31 articles.

1. The interaction of cationic liposomes with the skin-associated bacterium Staphylococcus epidermidis: effects of ionic strength and temperature

2. Encapsulation of Vancomycin and Gentamicin Within Cationic Liposomes for Inhibition of Growth ofStaphylococcus Epidermidis

3. Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: Experimental studies in animals

4. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

5. Immunogenicity of immunoliposomes: reactivity against species-specific IgG and liposomal phospholipids

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells;Journal of Antimicrobial Chemotherapy;2022-10-18

2. Nanocarriers for combating biofilms: Advantages and challenges;Journal of Applied Microbiology;2022-09-01

3. The effects of surface properties of liposomes on their activity against Pseudomonas aeruginosa PAO-1 biofilm;Journal of Drug Delivery Science and Technology;2020-06

4. Lipid-Based Antimicrobial Delivery-Systems for the Treatment of Bacterial Infections;Frontiers in Chemistry;2020-01-10

5. Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis;Frontiers in Bioengineering and Biotechnology;2019-12-17